Company profile
CNBX Pharmaceuticals Inc. CIK 1343009
Ticker
CNBX (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Bethesda, MD 20814
Fiscal year end
2025 (FY)
Key Financials
Revenue
$0
Net income
-$314.0K
Total assets
$18.4K
Total liabilities
—
Stockholders' equity
-$2.50M
Cash & equivalents
$15.1K
Operating income
-$271.7K
Operating cash flow
-$171.3K
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2025-12-01. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
-13,539.6%
CapEx / revenue
—
Operating cash flow / net income
0.55×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$0
-$314.0K
$18.4K
—
-$2.50M
2024
$130.1K
-$695.2K
$31.4K
—
-$2.48M
2023
$410.2K
-$3.71M
$499.0K
—
-$2.02M
2022
$30.0K
-$3.72M
$811.2K
—
$1.63M
2021
$0
-$3.19M
$3.08M
—
$1.81M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form SCHEDULE 13G/A
2026-08-14
Financials filed via
Form 10-K
filed 2025-12-01
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Bethesda, MD 20814
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:32 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.